Latest filing published 17 Oct 2022 for Axcella Health Inc., €6.2M. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Societe des Produits Nestle S.A. discloses dealings in Axcella Health Inc. to SEC (Form 4). We count 2 filings; the first trade dates from 16 March 2022 and the latest from 13 October 2022.
The open-market record is one-sided, with 2 purchases worth €11.6M and not one sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant.
The latest filing, published on 17 October 2022, reports an open-market purchase of €6.2M in Axcella Health Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations